MFDS — authorised 15 June 2005
- Marketing authorisation holder: PF PRISM CV
- Status: likely_approved
🇰🇷 Tygacil in South Korea
MFDS authorised Tygacil on 15 June 2005
Marketing authorisation
Tygacil in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Tygacil approved in South Korea?
Yes. MFDS authorised it on 15 June 2005.
Who is the marketing authorisation holder for Tygacil in South Korea?
PF PRISM CV holds the South Korean marketing authorisation.